Skip to product information
1 of 1

Elabscience

SKU:PKSH032561

Recombinant Human IL1R2/CD121b Protein (Fc Tag)

Recombinant Human IL1R2/CD121b Protein (Fc Tag)

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant Human IL1R2/CD121B Protein (FC Tag), a cutting-edge product designed to revolutionize the field of immunology. This protein, derived from advanced recombinant technology, showcases exceptional quality and efficacy.

The Recombinant Human IL1R2/CD121B Protein (FC Tag) is meticulously engineered to possess a fusion construct with a fragment crystallizable (FC) tag. This tag enhances the protein's stability, solubility, and overall performance, ensuring optimal results in various experimental applications.

With its remarkable affinity for the interleukin-1 receptor (IL1R2/CD121B), this protein exhibits unparalleled binding capabilities, enabling precise modulation of the IL1 signaling pathway. By effectively neutralizing the activity of IL1, this product holds immense potential in therapeutic interventions targeting inflammatory diseases and immune dysregulation.

Furthermore, the Recombinant Human IL1R2/CD121B Protein (FC Tag) boasts exceptional purity, as it is produced in a state-of-the-art facility under stringent quality control measures. This guarantees a highly reliable and consistent protein source, facilitating accurate and reproducible research outcomes.

The versatility of this product is further exemplified by its compatibility with a wide range of experimental techniques, including but not limited to ELISA, Western blotting, and functional assays. Researchers can confidently explore the intricate mechanisms of IL1 signaling and unravel novel insights into immune responses.

In summary, the Recombinant Human IL1R2/CD121B Protein (FC Tag) represents a breakthrough in immunological research, offering a potent tool for investigating the IL1 signaling pathway. Its exceptional quality, stability, and compatibility make it an indispensable asset for scientists and clinicians alike, propelling advancements in the understanding and treatment of immune-related disorders.
View full details